Safety and Efficacy of Gemtuzumab Ozogamicin in Combination With Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report From The Children's Oncology Group

PURPOSE: While gemtuzumab ozogamicin (GTMZ) is commonly used in the treatment of acute myeloid leukemia (AML) in combination with standard chemotherapy agents, the pediatric maximum-tolerated dose (MTD) of GMTZ in combination with chemotherapy has not been determined. PATIENTS AND METHODS: The Child...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Clin Oncol
Main Authors: Aplenc, Richard, Alonzo, Todd A., Gerbing, Robert B., Lange, Beverly J., Hurwitz, Craig A., Wells, Robert J., Bernstein, Irwin, Buckley, Patrick, Krimmel, Kathleen, Smith, Franklin O., Sievers, Eric L., Arceci, Robert J.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2008
נושאים:
Pediatric Oncology
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558626/
https://ncbi.nlm.nih.gov/pubmed/18467731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.0096
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים